AURKA, JUN, AR, MELK, and NCOA2 has not been previously reported to be related to HCV-HCC in individuals with T2DM, hence these genes might act as potential biomarkers for diagnosis of both diseases at early stage. This evidence concerns the gene AR and type 2 diabetes mellitus.